New-onset postpartum preeclampsia: epigenetic mechanism and prediction

References

• Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074.
   PubMed Web of Science ®Google Scholar
• Chames MC, Livingston JC, Ivester TS, et al. Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol. 2002;186(6):1174–1177.
   PubMed Web of Science ®Google Scholar
• Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ. 1994;309(6966):1395–1400.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181–192.
   PubMed Web of Science ®Google Scholar
• Cohen J, Vaiman D, Sibai BM, et al. Blood pressure changes during the first stage of labor and for the prediction of early postpartum preeclampsia: a prospective study. Eur J Obstet Gynecol Reprod Biol. 2015;184:103–107.
   PubMed Web of Science ®Google Scholar
• Verlohren S. Pre-eclampsia is primarily a placental disorder: FOR: pre-eclampsia is primarily a placental disorder. BJOG. 2017;124(11):1762.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol. 2014;10(8):466–480.
   PubMed Web of Science ®Google Scholar
• Bird A. Perceptions of epigenetics. Nature. 2007;447(7143):396–398.
   PubMed Web of Science ®Google Scholar
• Januar V, Desoye G, Novakovic B, et al. Epigenetic regulation of human placental function and pregnancy outcome: considerations for causal inference. Am J Obstet Gynecol. 2015;213(4 Suppl.):S182–S196.
   PubMed Web of Science ®Google Scholar
• Novakovic B, Saffery R. The ever growing complexity of placental epigenetics – role in adverse pregnancy outcomes and fetal programming. Placenta. 2012;33(12):959–970.
   PubMed Web of Science ®Google Scholar
• Kulkarni A, Chavan-Gautam P, Mehendale S, et al. Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol. 2011;30(2):79–84.
   PubMed Web of Science ®Google Scholar
• Yuen RK, Penaherrera MS, von Dadelszen P, et al. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet. 2010;18(9):1006–1012.
   PubMed Web of Science ®Google Scholar
• Chu T, Bunce K, Shaw P, et al. Comprehensive analysis of preeclampsia-associated DNA methylation in the placenta. PLOS One. 2014;9(9):e107318.
   PubMed Web of Science ®Google Scholar
• Blair JD, Langlois S, McFadden DE, et al. Overlapping DNA methylation profile between placentas with trisomy 16 and early-onset preeclampsia. Placenta. 2014;35(3):216–222.
   PubMed Web of Science ®Google Scholar
• Jia RZ, Zhang X, Hu P, et al. Screening for differential methylation status in human placenta in preeclampsia using a CpG island plus promoter us promoter microarray. Int J Mol Med. 2012;30(1):133–141.
   PubMed Web of Science ®Google Scholar
• Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315–1316.
   PubMed Web of Science ®Google Scholar
• Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847–2849.
   PubMed Web of Science ®Google Scholar
• Chong J, Wishart DS, Xia J. Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr Protoc Bioinformatics. 2019;68(1):e86.
   PubMedGoogle Scholar
• Worley B, Powers R. Multivariate analysis in metabolomics. Curr Metabolomics. 2013;1(1):92–107.
   PubMedGoogle Scholar
• Hall MA. Correlation-based feature selection for machine learning. PhD Thesis, The University of Waikato, 1999.
   Google Scholar
• Xia J, Broadhurst DI, Wilson M, et al. Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics. 2013;9(2):280–299.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Cho MH, Hersh CP, et al. DNA methylation profiling in human lung tissue identifies genes associated with COPD. Epigenetics. 2016;11(10):730–739.
   PubMed Web of Science ®Google Scholar
• Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology. 2009;24:147–158.
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Romero R, Savasan ZA, et al. Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med. 2011;24(10):1187–1207.
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Chaiworapongsa T, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med. 2009;22(11):1021–1038.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005.
   PubMed Web of Science ®Google Scholar
• Romero R, Chaiworapongsa T. Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state. J Clin Invest. 2013;123(7):2775–2777.
   PubMed Web of Science ®Google Scholar
• Cornelius DC. Preeclampsia: from inflammation to immunoregulation. Clin Med Insights Blood Disord. 2018;11:1179545X17752325.
   PubMedGoogle Scholar
• Harmon AC, Cornelius DC, Amaral LM, et al. The role of inflammation in the pathology of preeclampsia. Clin Sci. 2016;130(6):409–419.
   PubMed Web of Science ®Google Scholar
• Thiery JP. Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442–454.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, et al. Epithelial–mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890.
   PubMed Web of Science ®Google Scholar
• Trueb B, Amann R, Gerber SD. Role of FGFRL1 and other FGF signaling proteins in early kidney development. Cell Mol Life Sci. 2013;70(14):2505–2518.
   PubMed Web of Science ®Google Scholar
• Stulberg MJ, Lin A, Zhao H, et al. Crosstalk between Fgf and Wnt signaling in the zebrafish tailbud. Dev Biol. 2012;369(2):298–307.
   PubMed Web of Science ®Google Scholar
• Sonderegger S, Haslinger P, Sabri A, et al. Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation. Endocrinology. 2010;151(1):211–220.
   PubMed Web of Science ®Google Scholar
• Unadkat JD, Dahlin A, Vijay S. Placental drug transporters. Curr Drug Metab. 2004;5(1):125–131.
   PubMed Web of Science ®Google Scholar
• Brien ME, Boufaied I, Soglio DD, et al. Distinct inflammatory profile in preeclampsia and postpartum preeclampsia reveal unique mechanisms. Biol Reprod. 2018;100(1):187–194.
   Web of Science ®Google Scholar
• Goel A, Maski MR, Bajracharya S, et al. Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period. Circulation. 2015;132(18):1726–1733.
   PubMed Web of Science ®Google Scholar
• Al-Safi Z, Imudia AN, Filetti LC, et al. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol. 2011;118(5):1102–1107.
   PubMed Web of Science ®Google Scholar
• Filetti LC, Imudia AN, Al-Safi Z, et al. New onset delayed postpartum preeclampsia: different disorders? J Matern Fetal Neonatal Med. 2012;25(7):957–960.
   PubMed Web of Science ®Google Scholar
• Bigelow CA, Pereira GA, Warmsley A, et al. Risk factors for new-onset late postpartum preeclampsia in women without a history of preeclampsia. Am J Obstet Gynecol. 2014;210:338.e1–338.e8.
   PubMed Web of Science ®Google Scholar
• Skurnik G, Hurwitz S, McElrath TF, et al. Labor therapeutics and BMI as risk factors for postpartum preeclampsia: a case-control study. Pregnancy Hypertens. 2017;10:177–181.
   PubMed Web of Science ®Google Scholar
• Takaoka S, Ishii K, Taguchi T, et al. Clinical features and antenatal risk factors for postpartum-onset hypertensive disorders. Hypertens Pregnancy. 2016;35(1):22–31.
   PubMed Web of Science ®Google Scholar